CALGARY, AB - Decibel Cannabis Company Inc., a market leader in premium cannabis and extract manufactured products, is pleased to announce its unaudited interim financial results for the three month period ending March 31, 2024. "Despite the drop in revenue, we remain one of Canada's top brands by market share.  With a focused effort on our strategy, we expect an improved...

TORONTO and GLIL YAM, Israel -- IM Cannabis Corp., a leading medical cannabis company with operations in Israel and Germany, closed a non-brokered private placement of secured convertible debentures for aggregate proceeds of $2,091,977 in order to preserve its cash to support accelerated growth in Germany. The Debentures are being issued to holders of short-term loans and obligations owed by the Company or...

ST. LOUIS – Avail Professional Services, a leading service provider in accounting, finance and capital sourcing to a variety of industries, announced today it has named Jason Nelson as Chief Executive Officer of its Avail Ag Division. This new division delivers industry-specific support to new and existing businesses in multiple cannabis markets across the country. A seasoned veteran of the...

PHOENIX - 4Front Ventures Corp., a vertically integrated multi-state cannabis operator and retailer, today announced its results for the quarter ended March 31, 2024. All financial information is presented in U.S. dollars unless otherwise indicated. Q1 2024 Financial Highlights GAAP revenue from continuing operations of $18.8 million Adjusted EBITDA1 of $2.5 million $23 million senior secured debt converted to common equity by largest capital partner Management Commentary "We've...

LOS ANGELES -- Ispire Technology Inc., a leader in the development and commercialization of vaping technology and precision dosing, appointed Jim McCormick chief financial officer. The Company also announced the appointments of John Patterson as Senior Vice President of International Nicotine, Dennis Lider as Senior Vice President of Cannabis Product Sales, and David Hessler as Senior Vice President of Operations. "We're thrilled to announce this significant...

LONG BEACH, Calif. - Glass House Brands Inc., one of the fastest-growing vertically integrated cannabis companies in the U.S., today announced the appointment of former Protective Insurance Company Chairman and Interim CEO, John "Jay" D. Nichols Jr., as the newest member of the Company's Board of Directors, effective immediately. Kyle Kazan, Co-Founder, Chairman and CEO of Glass House stated, "We are...

DENVER -- GrowGeneration Corp. (GrowGen), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 Highlights Net sales decreased 3% quarter-over-quarter to $47.9 million Comparable store sales including e-commerce decreased 1.0% to the prior year, but was positive for...

WASHINGTON – The House Committee on Agriculture is conducting a hearing on the Farm Bill, which is up for its 5-year renewal after being continued from last year. The 2018 Farm Bill made the production and sale of hemp and hemp products legal for the first time in decades. The National Cannabis Industry Association (NCIA), the largest trade association representing...

NEW YORK – LeafLink, a cannabis wholesale platform, today announced a strategic partnership with CASA, the authority in retail data analysis and merchandise planning. This partnership offers retailers the leading “white glove” data analytics services from CASA, which works with the retailer’s current technology stack, making onboarding quick and efficient. CASA’s expert advisors review individual location data, providing detailed analysis and recommendations...

HERZLIYA, Israel, and CALGARY, AB -- Innocan Pharma Corporation is pleased to announce significant advancements in the regulatory process for its Liposome-Cannabidiol (LPT-CBD) technology, which provides an innovative solution in non-opioid pain management. The U.S. Food and Drug Administration ("FDA") has granted Innocan an Investigational New Drug ("IND") number and approved an initial meeting with the Company to discuss the strategic...